While the absence of PHD2 in endothelial cells appears to confer apparent metabolic benefits against obesity, systemic or endothelial-specific PHD2 deficiency also causes detrimental effects in the cardiopulmonary system. The gene discussed is EGLN1; the disease is obesity disorder.